Regis NU664C Family Psychiatric Mental Health I Final Exam |
Comprehensive Practice Questions & Detailed Rationales
2026/2027
Question 1
Which of the following Cytochrome P450 enzymes is primarily
responsible for the hepatic metabolism of many second-generation
antipsychotic medications, and is notably induced by cigarette smoking
hydrocarbons?
A. CYP2D6
B. CYP3A4
C. CYP1A2
D. CYP2C19
Correct Answer: C. CYP1A2
Detailed Rationale: CYP1A2 metabolizes several key psychotropics,
including clozapine and olanzapine. Polycyclic aromatic hydrocarbons in
tobacco smoke induce this enzyme, leading to accelerated clearance
and lower plasma concentrations.
Question 2
What is the primary neurochemical mechanism responsible for the
mood-stabilizing effects of Lithium in Bipolar Disorder?
A. Inhibition of inositol monophosphatase (IMPase) and protein kinase
C (PKC) signaling cascades
,B. Direct irreversible blockade of monoamine oxidase enzymes
C. Full agonism at central GABA-A receptor complexes
D. Blockade of peripheral alpha-1 adrenergic receptors
Correct Answer: A. Inhibition of inositol monophosphatase (IMPase)
and protein kinase C (PKC) signaling cascades
Detailed Rationale: Lithium exerts intracellular second-messenger
regulation by inhibiting IMPase and PKC, which dampens overactive
neuronal signaling pathways implicated in manic excitation.
Question 3
Which clinical specifier indicates that a patient with Major Depressive
Disorder experiences mood swings that worsen in the autumn and
winter months with full remission in spring?
A. Peripartum onset
B. With melancholic features
C. With seasonal pattern
D. With atypical features
Correct Answer: C. With seasonal pattern
Detailed Rationale: Seasonal pattern (formerly Seasonal Affective
Disorder) denotes a regular temporal relationship between the onset of
major depressive episodes and a specific time of the year.
Question 4
,What is the primary rationale for prescribing a mood stabilizer
alongside an antidepressant when treating a patient with Bipolar I
Disorder?
A. To prevent the precipitation of a manic or mixed switch episode
B. To accelerate the renal elimination of the antidepressant
C. To permanently cure the underlying genetic predisposition
D. To eliminate the need for routine laboratory monitoring
Correct Answer: A. To prevent the precipitation of a manic or mixed
switch episode
Detailed Rationale: Unprotected antidepressant monotherapy in
bipolar disorder carries a high risk of triggering acute mania,
hypomania, or rapid cycling, making concurrent mood stabilization
mandatory.
Question 5
What neurobiological abnormality is classically observed on
neuroimaging in patients diagnosed with Obsessive-Compulsive
Disorder (OCD)?
A. Hyperactivity within the cortico-striato-thalamo-cortical (CSTC) circuit
B. Atrophy and hypoplasia of the occipital visual cortex
C. Complete demyelination of the corpus callosum
D. Hypertrophy of the cerebellum and cerebellar tonsils
Correct Answer: A. Hyperactivity within the cortico-striato-thalamo-
cortical (CSTC) circuit
, Detailed Rationale: Dysregulation and hyper-connectivity within the
CSTC loop impair the brain's ability to filter out intrusive thoughts and
inhibit repetitive behavioral urges.
Question 6
Which clinical feature distinguishes Bipolar II Disorder from Bipolar I
Disorder?
A. The lifetime absence of any full manic episodes, requiring at least
one hypomanic episode and one major depressive episode
B. The presence of continuous rapid cycling spanning over ten years
C. Occurrence exclusively in geriatric populations over age 75
D. The complete absence of depressive episodes
Correct Answer: A. The lifetime absence of any full manic episodes,
requiring at least one hypomanic episode and one major depressive
episode
Detailed Rationale: Bipolar II requires a history of at least one
hypomanic episode and one major depressive episode, whereas Bipolar
I requires at least one full manic episode.
Question 7
What is the recommended pharmacological strategy when switching a
patient from an irreversible Monoamine Oxidase Inhibitor (MAOI) to a
Selective Serotonin Reuptake Inhibitor (SSRI)?
A. Allow a washout period of at least 2 weeks (5 half-lives) to allow for
de novo synthesis of MAO enzymes before initiating the SSRI to avoid
Serotonin Syndrome.
Comprehensive Practice Questions & Detailed Rationales
2026/2027
Question 1
Which of the following Cytochrome P450 enzymes is primarily
responsible for the hepatic metabolism of many second-generation
antipsychotic medications, and is notably induced by cigarette smoking
hydrocarbons?
A. CYP2D6
B. CYP3A4
C. CYP1A2
D. CYP2C19
Correct Answer: C. CYP1A2
Detailed Rationale: CYP1A2 metabolizes several key psychotropics,
including clozapine and olanzapine. Polycyclic aromatic hydrocarbons in
tobacco smoke induce this enzyme, leading to accelerated clearance
and lower plasma concentrations.
Question 2
What is the primary neurochemical mechanism responsible for the
mood-stabilizing effects of Lithium in Bipolar Disorder?
A. Inhibition of inositol monophosphatase (IMPase) and protein kinase
C (PKC) signaling cascades
,B. Direct irreversible blockade of monoamine oxidase enzymes
C. Full agonism at central GABA-A receptor complexes
D. Blockade of peripheral alpha-1 adrenergic receptors
Correct Answer: A. Inhibition of inositol monophosphatase (IMPase)
and protein kinase C (PKC) signaling cascades
Detailed Rationale: Lithium exerts intracellular second-messenger
regulation by inhibiting IMPase and PKC, which dampens overactive
neuronal signaling pathways implicated in manic excitation.
Question 3
Which clinical specifier indicates that a patient with Major Depressive
Disorder experiences mood swings that worsen in the autumn and
winter months with full remission in spring?
A. Peripartum onset
B. With melancholic features
C. With seasonal pattern
D. With atypical features
Correct Answer: C. With seasonal pattern
Detailed Rationale: Seasonal pattern (formerly Seasonal Affective
Disorder) denotes a regular temporal relationship between the onset of
major depressive episodes and a specific time of the year.
Question 4
,What is the primary rationale for prescribing a mood stabilizer
alongside an antidepressant when treating a patient with Bipolar I
Disorder?
A. To prevent the precipitation of a manic or mixed switch episode
B. To accelerate the renal elimination of the antidepressant
C. To permanently cure the underlying genetic predisposition
D. To eliminate the need for routine laboratory monitoring
Correct Answer: A. To prevent the precipitation of a manic or mixed
switch episode
Detailed Rationale: Unprotected antidepressant monotherapy in
bipolar disorder carries a high risk of triggering acute mania,
hypomania, or rapid cycling, making concurrent mood stabilization
mandatory.
Question 5
What neurobiological abnormality is classically observed on
neuroimaging in patients diagnosed with Obsessive-Compulsive
Disorder (OCD)?
A. Hyperactivity within the cortico-striato-thalamo-cortical (CSTC) circuit
B. Atrophy and hypoplasia of the occipital visual cortex
C. Complete demyelination of the corpus callosum
D. Hypertrophy of the cerebellum and cerebellar tonsils
Correct Answer: A. Hyperactivity within the cortico-striato-thalamo-
cortical (CSTC) circuit
, Detailed Rationale: Dysregulation and hyper-connectivity within the
CSTC loop impair the brain's ability to filter out intrusive thoughts and
inhibit repetitive behavioral urges.
Question 6
Which clinical feature distinguishes Bipolar II Disorder from Bipolar I
Disorder?
A. The lifetime absence of any full manic episodes, requiring at least
one hypomanic episode and one major depressive episode
B. The presence of continuous rapid cycling spanning over ten years
C. Occurrence exclusively in geriatric populations over age 75
D. The complete absence of depressive episodes
Correct Answer: A. The lifetime absence of any full manic episodes,
requiring at least one hypomanic episode and one major depressive
episode
Detailed Rationale: Bipolar II requires a history of at least one
hypomanic episode and one major depressive episode, whereas Bipolar
I requires at least one full manic episode.
Question 7
What is the recommended pharmacological strategy when switching a
patient from an irreversible Monoamine Oxidase Inhibitor (MAOI) to a
Selective Serotonin Reuptake Inhibitor (SSRI)?
A. Allow a washout period of at least 2 weeks (5 half-lives) to allow for
de novo synthesis of MAO enzymes before initiating the SSRI to avoid
Serotonin Syndrome.
